Clinical and Histological Study of a Novel Dermal Substitute

Skin Transplantation Clinical Trial

Official title:
Clinical and Histological Study of a Novel Dermal Substitute, NovoSorb® BTM, Used in the Treatment of Full-thickness Skin Defects

Status Recruiting

Clinical Trial Summary

The goal of this observational study is to compare a novel dermal substitute to a the current standard procedure in the treatment of full thickness skin defects. The main questions aim to answer are: • Is the skin elasticity treated with the novel dermal substitute better than the skin elasticity treated with the current standard procedure Participants skin elasticity will be measured by Cutometer® MPA-580 assessment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Skin Transplantation

Clinical Trial Details

NCT number	NCT06255990
Study type	Observational
Source	University Children's Hospital, Zurich
Contact	Sophie Böttcher, MD
Phone	+41442667111
Email	sophie.boettcher@kispi.uzh.ch
Status	Recruiting
Phase
Start date	January 15, 2024
Completion date	June 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02374528` - Negative Pressure Wound Therapy for Skin Grafts	N/A
Withdrawn	`NCT00362219` - Topical Morphine for Analgesia in Patients With Skin Grafts	Phase 3
Not yet recruiting	`NCT05666999` - Post-market Clinical Follow-up Study for a CE Marked Wound Care Product (FibDex®)	N/A
Completed	`NCT03980600` - NFC Dressing for Skin Graft Donor Sites	N/A
Enrolling by invitation	`NCT01133145` - Allogeneic Vascularized Knee Transplantation	N/A